UM
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows
Liu, Kunmeng1; Lin, Hui-Heng1,2; Pi, Rongbiao2,3,4; Mak, Shinghung2; Han, Yifan2; Hu, Yuanjia1,5
2018
Source PublicationEXPERT OPINION ON THERAPEUTIC PATENTS
ISSN1354-3776
Volume28Issue:4Pages:341-350
AbstractIntroduction: Today, over 20 million people suffer from Alzheimer's disease (AD) worldwide. AD has become a critical issue to human health, especially in aging societies, and therefore it is a research hotspot in the global scientific community. The technology flow method differs from traditional reviews generating an informative overview of the research and development (R&D) landscape in a specific technological area. We need such an updated method to get a general overview of the R&D of anti-AD drugs in light of the dramatic developments in this area in recent years.
KeywordAlzheimer's disease patent technology flow citation network research and development
DOI10.1080/13543776.2018.1439475
URLView the original
Indexed BySCI ; SSCI
Language英语
WOS Research AreaPharmacology & Pharmacy
WOS SubjectChemistry, Medicinal ; Pharmacology & Pharmacy
WOS IDWOS:000427055500006
PublisherTAYLOR & FRANCIS LTD
Fulltext Access
Citation statistics
Cited Times [WOS]:4   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionUniversity of Macau
Affiliation1.Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Macao, Peoples R China;
2.Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China;
3.Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Int Joint Lab SYSU PolyU HK Novel Antidementia Dr, Guangzhou, Guangdong, Peoples R China;
4.Sun Yat Sen Univ, Zhongshan Sch Med, Guangdong Prov Key Lab Brain Funct & Dis, Guangzhou, Guangdong, Peoples R China;
5.China Pharmaceut Univ, Res Ctr Natl Drug Policy & Ecosyst, Nanjing, Jiangsu, Peoples R China
First Author AffilicationUniversity of Macau
Recommended Citation
GB/T 7714
Liu, Kunmeng,Lin, Hui-Heng,Pi, Rongbiao,et al. Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows[J]. EXPERT OPINION ON THERAPEUTIC PATENTS,2018,28(4):341-350.
APA Liu, Kunmeng,Lin, Hui-Heng,Pi, Rongbiao,Mak, Shinghung,Han, Yifan,&Hu, Yuanjia.(2018).Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows.EXPERT OPINION ON THERAPEUTIC PATENTS,28(4),341-350.
MLA Liu, Kunmeng,et al."Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows".EXPERT OPINION ON THERAPEUTIC PATENTS 28.4(2018):341-350.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Liu, Kunmeng]'s Articles
[Lin, Hui-Heng]'s Articles
[Pi, Rongbiao]'s Articles
Baidu academic
Similar articles in Baidu academic
[Liu, Kunmeng]'s Articles
[Lin, Hui-Heng]'s Articles
[Pi, Rongbiao]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Liu, Kunmeng]'s Articles
[Lin, Hui-Heng]'s Articles
[Pi, Rongbiao]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.